17.16
View the full transcript and gain access to JoVE Core videos
Q1: What are the main sources of pharmaceutical poisoning?
Pharmaceutical poisoning arises from both therapeutic and non-therapeutic drug exposure. Therapeutic toxicity occurs when standard dosages cause adverse effects, such as CNS depression from barbiturates. Non-therapeutic sources include unintentional exposures like exploratory behavior in children and occupational hazards, as well as intentional poisonings from recreational drug abuse or deliberate self-harm.
Q2: How does the FDA monitor drug safety after medications reach the market?
The FDA operates the Adverse Event Reporting System to identify and prevent drug toxicities that only become apparent after market release. This system accepts mandatory reports from healthcare professionals and voluntary reports from consumers and manufacturers. These reports help detect emerging safety issues and inform regulatory decisions to protect public health.
Q3: What medication administration errors pose the greatest poisoning risks?
Errors in prescribing, dispensing, or administering medications significantly increase poisoning risks. To minimize these errors, healthcare systems should implement barcodes or electronic readers for medication preparation and administration. Computerized systems managing doses, allergy checks, and medication tracking throughout patient care provide additional safeguards against preventable adverse events.
Q4: Why do unintentional and intentional poisonings differ by age group?
Unintentional poisonings predominantly affect young children through exploratory behavior and environmental exposures. Adults more commonly experience intentional poisoning through recreational drug abuse, deliberate self-ingestion, or purposeful administration of toxic substances to others. Age-related differences in behavior, access to medications, and cognitive development drive these distinct poisoning patterns.
Q5: What systemic approaches reduce medication-related poisoning incidents?
Comprehensive strategies include unit-dose distribution systems, pharmacy-prepared intravenous solutions, and removal of high-risk medications like concentrated potassium chloride from patient care areas. Technology-based safeguards such as computerized order entry, dose and allergy checking, and medication tracking systems are essential. Enhanced drug information resources and improved access to pharmacists further strengthen patient safety.
Q6: How common is pharmaceutical poisoning in hospitalized patients?
Pharmaceutical poisoning impacts an estimated 2 million hospitalized patients in the United States annually, causing serious adverse drug responses. These incidents result from therapeutic toxicities, medication errors, and unintentional exposures. The scale of this problem underscores the critical importance of implementing comprehensive safety systems and monitoring protocols in healthcare settings.
Q7: What distinguishes therapeutic drug toxicity from other poisoning scenarios?
Therapeutic drug toxicity occurs when standard, prescribed dosages produce severe adverse effects despite appropriate medical use. Unlike accidental ingestions or intentional poisonings, therapeutic toxicity represents an inherent risk of the medication itself. Examples include CNS depression from barbiturates leading to coma, demonstrating that even correctly administered drugs can cause life-threatening complications.
Explore Related Chapters







